Tenbarge Bryce
Insider CIK 1682907 · PGNX Vice President, Commercial
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PGNX PROGENICS PHARMACEUTICALS | D To issuer deriv | 2020-06-19 | 2020-06-23 | 90,750 | — | $0 | 0 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | D To issuer deriv | 2020-06-19 | 2020-06-23 | 75,000 | — | $0 | 0 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | D To issuer deriv | 2020-06-19 | 2020-06-23 | 66,000 | — | $0 | 0 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | D To issuer deriv | 2020-06-19 | 2020-06-23 | 75,900 | — | $0 | 0 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | D To issuer deriv | 2020-06-19 | 2020-06-23 | 82,214 | — | $0 | 0 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2020-03-02 | 2020-03-04 | 82,214 | — | $0 | 82,214 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2019-03-01 | 2019-03-05 | 90,750 | — | $0 | 90,750 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2018-03-01 | 2018-03-02 | 75,900 | — | $0 | 75,900 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2017-03-01 | 2017-03-07 | 66,000 | — | $0 | 66,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2016-10-03 | 2016-10-04 | 75,000 | — | $0 | 75,000 | SEC↗ |